Navigation Links
I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
Date:2/23/2010

LA JOLLA, Calif., Feb. 23 /PRNewswire/ -- I3 Corporation announced today that the Company will be presenting on its lead product, the Q-FLO™ closed system, as a superior alternative to conventional closed systems for medication transport and delivery, at the In3 West Conference on March 4-5, 2010, at the Venetian Resort in Las Vegas, NV.

The Q-FLO™ is I3's lead product that encompasses a male and female luer lock mechanism for closed system medication transport and delivery.  The Q-FLO™ offers unique features and benefits for medication delivery, which include: a) a closed, no drop, valved connection system preventing drips and spillage of cytotoxic drugs, b) convenient locking mechanism allowing for a fast and easy mechanism to establish a patent connection; c) Passive 'Fool Proof' Safety System which seals off upon disconnection to help prevent exposure to hazardous compounds; d) first ever Visual Indicator that provides for a clear, color coded, visual confirmation of the status of the connection; e) the lowest internal residual volume of any closed system on the market; f) rotational actuation, which allows for a pumping action within the male luer connector offering the flexibility of creating a negative, positive, or neutral bolus effect, and finally g) safe material composition, which is entirely Latex, DEHP, and Silicon-free, making the Q-FLO™ an ideal connector system for the entire spectrum of chemotherapy and nuclear medicine drugs.

"The Q-FLO™ represents a significant advance in the state of the art of closed system devices, offering improved safety and convenience for healthcare workers administering cytotoxic drugs to patients around the world," stated Babak Nemati, Ph.D., President & CEO of I3.  "We are proud of the accomplishments of our design and development team, and we look forward to the commercial launch of this important product line with our distribution partners later this year."

In the current hospital environment, thousands of pharmacists, nurses, physicians and other caregivers may encounter a serious threat to their own physical and reproductive health, on a daily basis, through inadvertent exposure to cytotoxic drugs, such as chemotherapy, antivirals, antibiotics, hormones, nuclear medicine drugs.  The US federal government estimates that 5.5 million healthcare workers continue to be exposed to these substances each year.  Advances in closed systems such as the I3 Q-FLO™ offer the promise of creating a safe working environment for healthcare providers worldwide.

About I3 Corporation (www.infusioninnovations.net)

I3 is a La Jolla, California, based emerging medical device company focused on the design and development of innovative products for improved safety of the hospital environment.  Founded in 2006, I3 has a strong proprietary portfolio of products ranging from needle-less injection site connectors, to safety syringes, and bio-diagnostic sampling devices.  The fundamental driving philosophy behind our products is bringing key engineering innovation to improve safety, ease of use, and functionality of established hospital based products.

For more information, please contact us at info@infusioninnovations.net.

SOURCE I3 Corporation

Back to top

RELATED LINKS
http://www.infusioninnovations.net

'/>"/>

SOURCE I3 Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
2. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
3. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
7. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
8. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
9. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
10. Innovative Brain Scanning for Alzheimers Screening Unveiled
11. Gates Foundation Seeks Proposals for Innovative Global Health Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):